From WisPolitics.com/WisBusiness.com …
— UW-Madison and university spin-off company Immuto Scientific will seek to identify new drug targets to improve treatments for colorectal cancer patients.
The university today announced the collaborative agreement with the Madison-based company, which has a specialized platform for identifying new therapeutic targets that can’t be found by other approaches.
These “surface protein conformations,” or SPCs, could be used for safer and more precise treatments for solid colorectal cancer tumors, according to the announcement.
While the joint effort will hinge on the company’s platform, Immuto Scientific will also get access to unique human tissue models of cancer through the partnership.
This work will be led by Dr. Dustin Deming, a professor of medicine with the UW School of Medicine and Public Health. He says the university’s collection of patient-derived cancer models “enables exploration of tumor biology and therapeutic vulnerabilities” in ways that aren’t possible with traditional models.
Faraz Choudhury, co-founder and CEO of Immuto Scientific, says working with the university on this project is “an exceptional opportunity” to study colon cancer.
“By integrating patient-derived models with our structural surfaceomics platform, we can reveal previously unseen, disease-specific surface structures for drug targets that open new possibilities for therapeutic intervention,” he said in a statement.
Immuto Scientific is based on technology created by UW-Madison’s electrical engineering and biochemistry departments and patented by the Wisconsin Alumni Research Foundation.
See the release below.
Top Stories
– ACA enrollment drops by 1M-plus after subsidies expire
– US vaccine changes lead some parents to question other newborn care
– Americans are living longer: Why caregivers are headed for a crisis
– Genes May Control Your Longevity, However Healthily You Live
– Secretary Kennedy names new chair, 10 members to federal Alzheimer’s advisory panel
– This Teen Never Got His Day in Vaccine Court. His Former Lawyer Now Advises RFK on Its Overhaul.
Press Releases
– UW-Madison: Immuto Scientific to collaborate on novel cancer target discovery
– Milwaukee Area Health Education Center: Celebrates 2024-2025 High School Pathways Program success
